GILD
Gilead Sciences, Inc.Healthcare$139.71
▲ Bullish
Mkt Cap: $173.41B|Float: 1.24B|SI: 1.6%|DTC: 3.2
Data as of market close Apr 2, 2026
IV Rank
54
IV Pctl
78%
HV 20d
20.6%
52W Range
$91-$156
ATR(14)
$3.23
Exp. Move
±3.2%
P/C Ratio
0.54
Earnings
Apr 23
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Exp. Move Moderate
Low Put/Call
GILD Key Options Data
- IV Rank
- 53.9%
- Total GEX
- $0.01B
- Total DEX
- $4.2M
- Max Pain
- $140.00
- Expected Move
- ±3.2%
- Put/Call OI
- 0.54
- Net Premium
- $4.0M
- Spot Price
- $139.71
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$4.42 | ±3.2% | $135.30 | $144.13 |
| 2026-04-17 | 15 | ±$7.40 | ±5.3% | $132.31 | $147.11 |
| 2026-04-24 | 22 | ±$10.12 | ±7.3% | $129.59 | $149.84 |
| 2026-05-01 | 29 | ±$5.70 | ±4.1% | $134.01 | $145.41 |
| 2026-05-08 | 36 | ±$5.17 | ±3.7% | $134.54 | $144.89 |
| 2026-05-15 | 43 | ±$12.93 | ±9.3% | $126.79 | $152.64 |
Explore GILD options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.